Family Legacy, Inc. Amgen Inc Transaction History

Family Legacy, Inc.

$277 Million
Q2 2024

A detailed history of Family Legacy, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Family Legacy, Inc. holds 12,745 shares of AMGN stock, worth $4.11 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

12,745

Previous 12,729 0.13%

Holding current value

$4.11 Million

Previous $3.62 Million 10.03%

% of portfolio

1.44%

Previous 1.31%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $4,204 - $5,108	16 Added 0.13%	12,745 $3.98 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $272,365 - $328,779	-1,013 Reduced 7.37%	12,729 $3.62 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $1,789 - $2,019	-7 Reduced 0.05%	13,742 $3.96 Million
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $7,652 - $9,501	35 Added 0.26%	13,749 $3.7 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $5,356 - $6,334	-25 Reduced 0.18%	13,714 $3.04 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $36,126 - $44,032	160 Added 1.18%	13,739 $3.32 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $6,183 - $7,857	-27 Reduced 0.2%	13,579 $3.57 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $18,630 - $21,011	-83 Reduced 0.61%	13,606 $3.07 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $6,797 - $7,519	31 Added 0.23%	13,689 $3.31 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $88,899 - $101,737	447 Added 3.38%	13,658 $3.17 Million
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $4,438 - $4,923	19 Added 0.14%	13,211 $3.23 Million
Q1 2021 Apr 09, 2021	SELL	$221.91 - $258.6 $2,884 - $3,361	-13 Reduced 0.1%	13,192 $3.28 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $8,222 - $9,791	38 Added 0.29%	13,205 $3.04 Million
Q3 2020 Oct 09, 2020	BUY	$234.65 - $260.95 $10,793 - $12,003	46 Added 0.35%	13,167 $3.35 Million
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $5,934 - $7,282	-30 Reduced 0.23%	13,121 $3.1 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $9,840 - $13,051	54 Added 0.41%	13,151 $2.67 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $10,028 - $12,889	-53 Reduced 0.4%	13,097 $3.12 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $330,286 - $395,752	1,897 Added 16.86%	13,150 $2.87 Million
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $49,509 - $58,036	297 Added 2.71%	11,253 $2.07 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $2,713 - $3,058	15 Added 0.14%	10,956 $2.14 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $30,149 - $35,194	169 Added 1.57%	10,941 $2.13 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $95,980 - $108,205	-518 Reduced 4.59%	10,772 $2.23 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $33,043 - $37,115	199 Added 1.79%	11,290 $2.08 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $5,252 - $6,138	31 Added 0.28%	11,091 $1.89 Million
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $769,682 - $859,970	4,560 Added 70.15%	11,060 $1.92 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $1.09 Million - $1.24 Million	6,500	6,500 $1.21 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Legacy, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Legacy, Inc. with notifications on news.

Account

Family Legacy, Inc. Amgen Inc Transaction History